Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Endocyte ECYT

Healthcare Biotechnology
"Endocyte Inc is a biopharmaceutical company. It is engaged in developing targeted therapies for the treatment of cancer and inflammatory diseases."

Recent & Breaking News (NDAQ:ECYT)

Endocyte to Present Data on EC1456 at the European Cancer Congress 2015

GlobeNewswire September 21, 2015

Endocyte Announces Final Overall Survival Results From Phase 2b TARGET Trial in Non-Small Cell Lung Cancer Patients

GlobeNewswire September 7, 2015

Endocyte to Present at Upcoming Healthcare Conferences

GlobeNewswire September 3, 2015

Endocyte Announces Presentations at the 250th American Chemical Society National Meeting & Exposition

GlobeNewswire August 12, 2015

Endocyte Reports Second Quarter 2015 Financial Results and Provides Update on Clinical Progress

GlobeNewswire August 4, 2015

Endocyte Appoints Dr. Alison A. Armour as Chief Medical Officer

GlobeNewswire August 4, 2015

Endocyte to Present at the 2015 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 3, 2015

Endocyte Announces Second Quarter 2015 Earnings Conference Call

GlobeNewswire July 28, 2015

Endocyte to Present at the Cantor Fitzgerald Healthcare Conference

GlobeNewswire July 1, 2015

Endocyte Announces Updated Data on EC1456 and EC1169 at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire May 13, 2015

Endocyte Reports First Quarter 2015 Financial Results and Provides Update on Clinical Progress

GlobeNewswire May 7, 2015

Endocyte Announces First Quarter 2015 Earnings Conference Call

GlobeNewswire April 30, 2015

Endocyte Announces Presentations at American Association for Cancer Research (AACR) 2015 Annual Meeting

GlobeNewswire April 10, 2015

Endocyte Appoints P. David Mozley, M.D. as Vice President of Imaging

GlobeNewswire April 7, 2015

Endocyte to Present at the 2015 Annual Meeting on Women's Cancer for the Society of Gynecologic Oncology (SGO)

GlobeNewswire March 20, 2015

Endocyte Reports Fourth Quarter and Year End 2014 Financial Results and Provides Clinical Update

GlobeNewswire March 2, 2015

Endocyte to Present Data on EC1456 and EC1169 at the International Congress on Targeted Anticancer Therapies in Paris

GlobeNewswire February 27, 2015

Endocyte Announces Fourth Quarter and Full Year 2014 Earnings Conference Call

GlobeNewswire February 23, 2015

Endocyte to Present at Upcoming Conferences

GlobeNewswire February 17, 2015

Endocyte Reports Third Quarter Financial Results and Provides Clinical Update

GlobeNewswire November 5, 2014